Tikva Allocell to Present Preclinical CAR-EBVST Data at ACR Convergence 2026
Tikva Allocell has been chosen to present preclinical data on its CD19.SB9.CAR-EBVST candidate at ACR Convergence 2026, FirstWord Pharma reports.
Oct 22, 2026 · 1 min read
67 views